..........Wait a few minutes for loading data

DIAGNOSTICS

M. Gion "Cancer biomarkers in the clinical practice: state of the art and future directions"(Section 1)



M. Gion "Cancer biomarkers in the clinical practice: state of the art and future directions"(Section 2)

M. Gion "Cancer biomarkers in the clinical practice: state of the art and future directions"(Section 3)



F. Bussolino: "Biomarkers and surrogate end-points in anti-angiogenic therapies:
a paradigmatic example for targeted drugs" (Section 1)


F. Bussolino: "Biomarkers and surrogate end-points in anti-angiogenic therapies:
a paradigmatic example for targeted drugs" (Section 2)


M. Boamfa (Philips): "Fluorescence Detection for Immunoassays and DNA sensing -
from optical table to miniaturized biosensor devices"(Section 1).


M. Boamfa (Philips): "Fluorescence Detection for Immunoassays and DNA sensing -
from optical table to miniaturized biosensor devices"(Section 2)



F. Uggeri ( Bracco): "In vivo Diagnostic Imaging: from Contrast Media to Molecular Probes. 8Section 1)


F. Uggeri ( Bracco): "In vivo Diagnostic Imaging: from Contrast Media to Molecular Probes (Section 2)